Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  protein tyrosine kinase >  Vatalanib Dihydrochloride

Vatalanib Dihydrochloride

Basic information Safety Supplier Related

Vatalanib Dihydrochloride Basic information

Product Name:
Vatalanib Dihydrochloride
Synonyms:
  • CGP-79787 Dihydrochlorid
  • N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine Dihydrochloride
  • Vatalanib Dihydrochloride
  • CGP-79787 Dihydrochloride
  • Vatalanib 2hcl((ZK-222584,PTK 787)
  • Vatalanib dihydrochloride (PTK787)
  • CGP-79787
  • CGP-79787D
CAS:
212141-51-0
MF:
C20H17Cl3N4
MW:
419.74
Product Categories:
  • Heterocycles
  • Tyrosine Kinase Inhibitors
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Antineoplastic
  • Inhibitors
Mol File:
212141-51-0.mol
More
Less

Vatalanib Dihydrochloride Chemical Properties

Melting point:
268-2700C
storage temp. 
Inert atmosphere,Store in freezer, under -20°C
solubility 
Soluble in DMSO (up to 20 mg/ml with warming) or in Water (up to 100 mg/ml)
form 
solid
color 
White or off-white
Stability:
Stable for 2 years from date of purchase as supplied. Solutions in DMSO or distilled water may be stored at -20°C for up to 3 months.
CAS DataBase Reference
212141-51-0
More
Less

Safety Information

Risk Statements 
36/37/38
Safety Statements 
24/25
HS Code 
29333990
More
Less

Vatalanib Dihydrochloride Usage And Synthesis

Description

Vatalanib is an antagonist of the VEGF receptors, inhibiting the receptor tyrosine kinase activities of VEGFR1 (Flt1), VEGFR2 (KDR), and VEGFR3 (Flt4) with IC50 values of 77, 37, and 190 nM, respectively. It less potently inhibits PDGF and c-Kit (IC50 = 600 and 700 nM) and has no effect on a large panel of additional kinases. Vatalanib completely blocks retinal neovascularization in oxygen-induced ischemic retinopathy in mice, suggesting its use in diabetic retinopathy and other diseases featuring aberrant vascular development.

Chemical Properties

White to Off-White Crystalline Powder

Uses

Vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor. Antineoplastic.

Uses

Vatalanib (PTK787) is an inhibitor of VEGFR2/KDR, Flt-1 and c-Kit with IC50 of 37 nM, 77 nM and 730 nM, respectively.

References

1) Wood?et al. (2000),?PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration;? Cancer Res.,?60?2178 2) Lin?et al. (2002),?The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in bone marrow microenvironment;? Cancer Res.,?62?5019

Vatalanib DihydrochlorideSupplier

J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Email
sales@BioChemBest.com
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Jinan Trio PharmaTech Co., Ltd.
Tel
+86 (531) 88811783
Email
sales@trio-pharmatech.com (International market)
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
meilunui@163.com